Literature DB >> 15274866

[Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15274866      PMCID： PMC7128316          DOI： 10.1016/s1579-2129(06)60322-4

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  82 in total

1.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

Authors:  B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

2.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

3.  Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.

Authors:  R Menéndez; J Córdoba; P de La Cuadra; M J Cremades; J L López-Hontagas; M Salavert; M Gobernado
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

Review 4.  Community-acquired pneumonia.

Authors:  T J Marrie
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

5.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

6.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Authors:  C G Whitney; M M Farley; J Hadler; L H Harrison; C Lexau; A Reingold; L Lefkowitz; P R Cieslak; M Cetron; E R Zell; J H Jorgensen; A Schuchat
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

Review 8.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

9.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

10.  A three-year study of severe community-acquired pneumonia with emphasis on outcome.

Authors:  J Rello; E Quintana; V Ausina; A Net; G Prats
Journal:  Chest       Date:  1993-01       Impact factor: 9.410
View more
  5 in total

Review 1.  Antibiotics for community-acquired pneumonia in adult outpatients.

Authors:  Smita Pakhale; Sunita Mulpuru; Theo J M Verheij; Michael M Kochen; Gernot G U Rohde; Lise M Bjerre
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09

2.  2018 recommendations for the management of community acquired pneumonia.

Authors:  Ricardo de Amorim Corrêa; Andre Nathan Costa; Fernando Lundgren; Lessandra Michelin; Mara Rúbia Figueiredo; Marcelo Holanda; Mauro Gomes; Paulo José Zimermann Teixeira; Ricardo Martins; Rodney Silva; Rodrigo Abensur Athanazio; Rosemeri Maurici da Silva; Mônica Corso Pereira
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

Review 3.  [Pneumonia awareness year, 2004: scientific impact through publications in Archivos de Bronconeumología].

Authors:  Olga Rajas Naranjo; Javier Aspa Marco
Journal:  Arch Bronconeumol       Date:  2006-10       Impact factor: 4.872

Review 4.  [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features].

Authors:  F Philippart
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

Review 5.  Viral-bacterial interactions-therapeutic implications.

Authors:  Jane C Deng
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.